Analyze Diet
Equine veterinary journal2019; 51(6); 733-737; doi: 10.1111/evj.13110

The effect of insulin infusion on heart rate and systemic blood pressure in horses with equine metabolic syndrome.

Abstract: There is little evidence that horses with equine metabolic syndrome (EMS) have higher resting blood pressures than horses with normal insulin sensitivity. However, there are indications that EMS horses have an altered dynamic response to the cardiovascular effects of insulin. Objective: To examine heart rate and the systemic blood pressure response in EMS and control horses during insulin infusion. Methods: Cross-sectional study. Methods: Horses were examined with an oral sugar test (OST) and a euglycaemic hyperinsulinaemic clamp (EHC). Based on the results from the OST, the horses were classified as either EMS or control. Blood pressure was measured before the start of the EHC and at 60, 120 and 180 min of the EHC. Results: There were 16 EMS and 12 control horses. Mean resting heart rate was higher for EMS horses compared with control (35.6 ± 5.1 vs. 30.3 ± 3.5 beats/min). Systolic, diastolic and mean arterial blood pressure did not differ between groups at the start of the EHC. Blood pressure decreased gradually during the EHC in the control group, whereas the EMS group showed no decline in systolic, diastolic or mean arterial pressure. Conclusions: Limited number of horses. Conclusions: Horses with EMS have cardiovascular changes that affect resting heart rate and systemic blood pressure during insulin infusion.
Publication Date: 2019-04-05 PubMed ID: 30887546DOI: 10.1111/evj.13110Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study sought to understand how insulin infusion impacts the heart rate and systemic blood pressure of horses diagnosed with equine metabolic syndrome (EMS), finding that such horses exhibit greater resting heart rates, and unlike healthy horses, their blood pressure doesn’t decrease during insulin infusion.

Objective and Methods

  • The aim of this research was to study the difference in heart rate and blood pressure response during insulin infusion between horses with equine metabolic syndrome (EMS) and those without (control group).
  • To determine the groupings, an oral sugar test (OST) and a euglycaemic hyperinsulinaemic clamp (EHC), which are standard diagnostic tests for EMS, were performed on all horses.
  • If a horse registered a certain level on the OST, it was classified as having EMS. If it didn’t, it was placed in the control group.
  • The researchers monitored the blood pressure of these horses before and at specific intervals throughout the duration of the EHC.

Results

  • A total of 28 horses (16 EMS and 12 control) were involved in the study.
  • The results uncovered that horses with EMS had higher average resting heart rates than the control group. Specifically, the average resting heart rate for EMS horses was measured at 35.6 beats per minute, in contrast to the control group’s 30.3 beats per minute.
  • Both groups started with the same levels of systolic, diastolic, and mean arterial blood pressure.
  • Throughout the EHC, the control group’s blood pressure decreased progressively. In contrast, the EMS group maintained the same levels of systolic, diastolic, or mean arterial pressure, showing no decline.

Conclusions

  • The study suffers from a limited number of horses, which could impact the generalizability of its findings.
  • Despite this limitation, the research established that horses with EMS have notable cardiovascular changes in terms of resting heart rate and adaption of systemic blood pressure in response to insulin infusion.
  • These insights are significant given the potential for the careful management and treatment of EMS in horses.

Cite This Article

APA
Nostell K, Lindåse S, Edberg H, Bröjer J. (2019). The effect of insulin infusion on heart rate and systemic blood pressure in horses with equine metabolic syndrome. Equine Vet J, 51(6), 733-737. https://doi.org/10.1111/evj.13110

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 51
Issue: 6
Pages: 733-737

Researcher Affiliations

Nostell, K
  • Department of Clinical Sciences, Swedish University of Agricultural Sciences (SLU), Uppsala, Sweden.
Lindåse, S
  • Department of Clinical Sciences, Swedish University of Agricultural Sciences (SLU), Uppsala, Sweden.
Edberg, H
  • Department of Clinical Sciences, Swedish University of Agricultural Sciences (SLU), Uppsala, Sweden.
Bröjer, J
  • Department of Clinical Sciences, Swedish University of Agricultural Sciences (SLU), Uppsala, Sweden.

MeSH Terms

  • Animals
  • Blood Pressure
  • Glucose Clamp Technique
  • Horse Diseases / blood
  • Horse Diseases / physiopathology
  • Horses
  • Insulin
  • Insulin Resistance / physiology
  • Metabolic Syndrome / physiopathology
  • Metabolic Syndrome / veterinary

Grant Funding

  • Swedish - Norwegian Foundation for Equine Research

References

This article includes 40 references
  1. Morgan RA, Keen JA, Walker BR, Hadoke PW. Vascular dysfunction in horses with endocrinopathic laminitis. PLoS One 11, e0163815.
  2. Heliczer N, Gerber V, Bruckmaier R, van der Kolk JH, Navas de Solis C. Cardiovascular findings in ponies with equine metabolic syndrome. J. Am. Vet. Med. Ass. 250, 1027-1035.
  3. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Invest. 98, 894-898.
  4. Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, Quon MJ. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101, 1539-1545.
  5. Muniyappa R, Montagnani M, Kon Koh K, Quon MJ. Cardiovascular actions of insulin. Endocr. Rev. 28, 463-491.
  6. Formoso G, Chen H, Kim J, Montagnani M, Consoli A, Quon MJ. Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-dependent pathways in vascular endothelium. Mol. Endocrinol. 20, 1153-1163.
  7. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J. Clin. Invest. 55, 845-855.
  8. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest. 97, 2601-2610.
  9. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J. Clin. Invest. 105, 311-320.
  10. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87, 2246-2252.
  11. Laakso M, Edelman S, Brechtel G, Baron A. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J. Clin. Invest. 85, 1844-1852.
  12. Heise T, Magnusson K, Heinemann L, Sawicki P. Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension 32, 243-248.
  13. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Järvinen H, Capaldo B, Lehtovirta M, Jacob S, Yki-Järvinen H. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension 30, 1144-1149.
  14. Nostell K, Lindåse S, Bröjer JT. Blood pressure in warmblood horses before and during a euglycemic-hyperinsulinemic clamp. Acta Vet. Scand. 58, Suppl. 1, 65.
  15. Henneke DR, Potter GD, Kreider JL, Yeats BF. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet. J. 15, 371-372.
  16. Carter RA, Geor RJ, Burton Staniar W, Cubitt TA, Harris PA. Apparent adiposity assessed by standardised scoring systems and morphometric measurements in horses and ponies. Vet. J. 172, 204-210.
  17. Lindåse S, Nostell K, Bröjer J. A modified oral sugar test for evaluation of insulin and glucose dynamics in horses. Acta Vet. Scand. 20, 64.
  18. Öberg J, Bröjer J, Wattle O, Lilliehöök I. Evaluation of an equine-optimized enzyme-linked immunosorbent assay for serum insulin measurement and stability study of equine serum insulin. Comp. Clin. Path. 21, 1291-1300.
  19. Lindåse SEA, Brojer J. Evaluation of an oral sugar test to diagnose insulin dysregulation in horses. J Vet Intern. Med. 33, 2183.
  20. Lindåse SS, Nostell KE, Müller CE, Jensen-Waern M, Bröjer J. Effects of diet-induced weight gain and turnout to pasture in insulin sensitivity in moderately insulin - resistant horses. Am. J. Vet. Res. 77, 300-309.
  21. Pratt SE, Geor RJ, McCutcheon LJ. Effects of dietary energy source and physical conditioning on insulin sensitivity and glucose tolerance in standardbred horses. Equine Vet. J. 38, Suppl. 36, 579-584.
  22. Slough TL, Gunkel CD, Murray LW, Drouillard JS. A comparison of methodologies for measuring glucose concentrations in the horse. Prof. Anim. Sci. 27, 204-214.
  23. Pratt-Phillips SE, Geor RJ, McCutcheon LJ. Comparison among the euglycemic-hyperinsulinemic clamp, insulin-modified frequently sampled intravenous glucose tolerance test, and oral glucose tolerance test for assessment of insulin sensitivity in healthy Standardbreds. Am. J. Vet. Res. 76, 84-91.
  24. Söder J, Bröjer J, Nostell K. Interday variation and effect of transportation on indirect blood pressure measurements, plasma endothelin-1 and serum cortisol in Standardbred and Icelandic horses. Acta Vet. Scand. 54, 37.
  25. Walders W, Gehlen H. Noninvasive blood pressure measurement using high definition oscillometry in horses with heart diseases. Tierarztl. Prax. Ausg. G. Grosstiere Nutztiere 421, 22-31.
  26. Tünsmeyer J, Hopster K, Feige K, Kästner SB. Agreement of high definition oscillometry with direct arterial blood pressure measurement at different blood pressure ranges in horses under general anaesthesia. Vet Anaesth. Analg. 42, 286-291.
  27. Brown S, Atkins C, Bagley R, Carr A, Cowgill L, Davidson M, Egner B, Elliott J, Henik R, Labato M, Littman M, Polzin D, Ross L, Snyder P, Stepien R. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J. Vet. Intern. Med. 21, 542-558.
  28. Nostell K, Lindåse S, Bröjer B. Blood pressure and cortisol in horses with diet induced obesity and effect of pasture. Abstract ACVIM congress, Seattle. .
  29. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95, 2409-2415.
  30. Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, Smyth GK, Wabitsch M, O'Brien PE, Harrison LC. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 59, 1648-1656.
  31. Zeyda M, Gollinger K, Kriehuber E, Kiefer FW, Neuhofer A, Stulnig TM. Newly identified adipose tissue macrophage populations in obesity with distinct chemokine and chemokine receptor expression. Int. J. Obes. (Lond.) 34, 1648-1694.
  32. Rowe J, Young J, Minaker K, Stevens A, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30, 219-225.
  33. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45, 356-362.
  34. Aghamohammadzadeh R, Heagerty AM. Obesity-related hypertension: epidemiology, pathophysiology, treatments, and the contribution of perivascular adipose tissue. Ann. Med. 44, Suppl. 1, S74-S84.
  35. Kang YS. Obesity associated hypertension: new insights into mechanism. Electrolyte Blood Press. 11, 46-52.
  36. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 349, 837-842.
  37. Gauff F, Patan-Zugaj B, Licka TF. Hyperinsulinaemia increases vascular resistance and endothelin-1 expression in the equine digit. Equine Vet. J. 45, 613-618.
  38. Venugopal CS, Eades S, Holmes EP, Beadle R. Insulin resistance in equine digital vessel rings: an in vitro model to study vascular dysfunction in equine laminitis. Equine Vet. J. 43, 744-749.
  39. Keen JA, McGorum BC, Hillier C, Nally JE. Short-term incubation of equine laminar veins with cortisol and insulin alters contractility in vitro: possible implications for the pathogenesis of equine laminitis. J. Vet. Pharmacol. Ther. 36, 382-388.
  40. Lloyd-Jones DM, Liu K, Colangelo LA, Yan LL, Klein L, Loria CM, Lewis CE, Savage P. Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study. Circulation 115, 1004-1011.

Citations

This article has been cited 3 times.
  1. D' Fonseca NMM, Beukers M, Wijnberg ID, Navas de Solis C, de Ruijter-Villani M, van Doorn DA, Stout TAE, Roelfsema E. Effect of a long-term high-energy diet on cardiovascular parameters in Shetland pony mares.. J Vet Intern Med 2021 Sep;35(5):2427-2436.
    doi: 10.1111/jvim.16229pubmed: 34350640google scholar: lookup
  2. Lindåse S, Nostell K, Bergsten P, Forslund A, Bröjer J. Evaluation of fasting plasma insulin and proxy measurements to assess insulin sensitivity in horses.. BMC Vet Res 2021 Feb 15;17(1):78.
    doi: 10.1186/s12917-021-02781-5pubmed: 33588833google scholar: lookup
  3. da Silva AA, do Carmo JM, Li X, Wang Z, Mouton AJ, Hall JE. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.. Can J Cardiol 2020 May;36(5):671-682.
    doi: 10.1016/j.cjca.2020.02.066pubmed: 32389340google scholar: lookup